ZA991148B - Nucleosides. - Google Patents
Nucleosides.Info
- Publication number
- ZA991148B ZA991148B ZA9901148A ZA991148A ZA991148B ZA 991148 B ZA991148 B ZA 991148B ZA 9901148 A ZA9901148 A ZA 9901148A ZA 991148 A ZA991148 A ZA 991148A ZA 991148 B ZA991148 B ZA 991148B
- Authority
- ZA
- South Africa
- Prior art keywords
- nucleosides
- hiv
- compounds
- independently
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW087113427A TWI198092B (en) | 1999-02-12 | 1999-02-12 | Nucleosides |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9800452A SE9800452D0 (sv) | 1998-02-13 | 1998-02-13 | Antivirals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA991148B true ZA991148B (en) | 1999-08-12 |
Family
ID=20410196
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9901148A ZA991148B (en) | 1998-02-13 | 1999-02-12 | Nucleosides. |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1058687B1 (pt) |
| JP (1) | JP4413427B2 (pt) |
| KR (1) | KR100565388B1 (pt) |
| CN (1) | CN1255422C (pt) |
| AT (1) | ATE256140T1 (pt) |
| AU (1) | AU732408B2 (pt) |
| CA (1) | CA2318975A1 (pt) |
| DE (1) | DE69913499T2 (pt) |
| DK (1) | DK1058687T3 (pt) |
| ES (1) | ES2211116T3 (pt) |
| HK (1) | HK1035907A1 (pt) |
| HU (1) | HUP0100879A3 (pt) |
| IL (1) | IL137605A (pt) |
| MY (1) | MY121813A (pt) |
| NZ (1) | NZ506033A (pt) |
| PL (1) | PL190284B1 (pt) |
| PT (1) | PT1058687E (pt) |
| SE (1) | SE9800452D0 (pt) |
| SI (1) | SI1058687T1 (pt) |
| TR (1) | TR200002318T2 (pt) |
| WO (1) | WO1999041268A1 (pt) |
| ZA (1) | ZA991148B (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6432966B2 (en) * | 1999-10-29 | 2002-08-13 | Smithkline Beecham Corporation | Antiviral combinations |
| WO2004087140A1 (en) * | 2003-03-27 | 2004-10-14 | Boehringer Ingelheim International Gmbh | Antiviral combination of a dipyridodiazepinone and a further antiretroviral compound |
| EP1610797A1 (en) * | 2003-03-27 | 2006-01-04 | Boehringer Ingelheim International GmbH | Antiviral combination of nevirapine and a further antiretroviral compound |
| EP1610781A1 (en) | 2003-03-27 | 2006-01-04 | Boehringer Ingelheim International GmbH | Antiviral combination of tipranavir and a further antiretroviral compound |
| DE10321905A1 (de) * | 2003-05-05 | 2004-12-09 | Eberhard-Karls-Universität Tübingen | Verwendung von Kombinationen aus Hemmern der reversen Transkriptase und Hemmern der viruscodierten DNA-Polymerase |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8602981D0 (sv) * | 1986-07-04 | 1986-07-04 | Astra Laekemedel Ab | Novel medicinal use |
| IL100874A (en) * | 1991-02-08 | 1996-01-19 | Pro Neuron Inc | Oxiforin nucleosides and their composition, for use as medicines, their preparation and pharmaceutical preparations containing them |
| DE4311801A1 (de) * | 1993-04-09 | 1994-10-13 | Hoechst Ag | Neue Carbonsäureester von 2-Amino-7-(1,3-dihydroxy-2-propoxymethyl)purin, deren Herstellung sowie deren Verwendung |
| US5543414A (en) * | 1994-07-28 | 1996-08-06 | Syntex (Usa) Inc. | Achiral amino acid acyl esters of ganciclovir and its derivatives |
-
1998
- 1998-02-13 SE SE9800452A patent/SE9800452D0/xx unknown
- 1998-08-14 PL PL98366358A patent/PL190284B1/pl not_active IP Right Cessation
-
1999
- 1999-02-12 NZ NZ506033A patent/NZ506033A/en not_active IP Right Cessation
- 1999-02-12 MY MYPI99000515A patent/MY121813A/en unknown
- 1999-02-12 AT AT99932499T patent/ATE256140T1/de not_active IP Right Cessation
- 1999-02-12 HU HU0100879A patent/HUP0100879A3/hu unknown
- 1999-02-12 DE DE69913499T patent/DE69913499T2/de not_active Expired - Fee Related
- 1999-02-12 EP EP99932499A patent/EP1058687B1/en not_active Expired - Lifetime
- 1999-02-12 CN CNB998028851A patent/CN1255422C/zh not_active Expired - Fee Related
- 1999-02-12 CA CA002318975A patent/CA2318975A1/en not_active Abandoned
- 1999-02-12 ZA ZA9901148A patent/ZA991148B/xx unknown
- 1999-02-12 SI SI9930467T patent/SI1058687T1/xx unknown
- 1999-02-12 DK DK99932499T patent/DK1058687T3/da active
- 1999-02-12 WO PCT/SE1999/000189 patent/WO1999041268A1/en active IP Right Grant
- 1999-02-12 PT PT99932499T patent/PT1058687E/pt unknown
- 1999-02-12 KR KR1020007008862A patent/KR100565388B1/ko not_active IP Right Cessation
- 1999-02-12 JP JP2000531460A patent/JP4413427B2/ja not_active Expired - Fee Related
- 1999-02-12 ES ES99932499T patent/ES2211116T3/es not_active Expired - Lifetime
- 1999-02-12 AU AU32819/99A patent/AU732408B2/en not_active Ceased
- 1999-02-12 TR TR2000/02318T patent/TR200002318T2/xx unknown
-
2000
- 2000-07-31 IL IL137605A patent/IL137605A/en unknown
-
2001
- 2001-09-18 HK HK01106601A patent/HK1035907A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| MY121813A (en) | 2006-02-28 |
| JP4413427B2 (ja) | 2010-02-10 |
| EP1058687B1 (en) | 2003-12-10 |
| CN1290268A (zh) | 2001-04-04 |
| HUP0100879A2 (hu) | 2002-04-29 |
| TR200002318T2 (tr) | 2000-11-21 |
| KR20010074428A (ko) | 2001-08-04 |
| DE69913499T2 (de) | 2004-10-28 |
| PT1058687E (pt) | 2004-03-31 |
| AU3281999A (en) | 1999-08-30 |
| ATE256140T1 (de) | 2003-12-15 |
| DE69913499D1 (en) | 2004-01-22 |
| PL190284B1 (pl) | 2005-11-30 |
| CA2318975A1 (en) | 1999-08-19 |
| WO1999041268A1 (en) | 1999-08-19 |
| SI1058687T1 (en) | 2004-02-29 |
| HUP0100879A3 (en) | 2002-08-28 |
| AU732408B2 (en) | 2001-04-26 |
| EP1058687A1 (en) | 2000-12-13 |
| NZ506033A (en) | 2002-02-01 |
| SE9800452D0 (sv) | 1998-02-13 |
| HK1035907A1 (en) | 2001-12-14 |
| IL137605A (en) | 2006-12-31 |
| JP2002503670A (ja) | 2002-02-05 |
| CN1255422C (zh) | 2006-05-10 |
| ES2211116T3 (es) | 2004-07-01 |
| DK1058687T3 (da) | 2004-03-15 |
| KR100565388B1 (ko) | 2006-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2217952A1 (en) | A pharmaceutical composition containing benzimidazole for inhibiting the growth of cancers | |
| GB0106661D0 (en) | Pharmaceutically active compounds | |
| EP0357571A3 (en) | Pyrimidine nucleosides and intermediates | |
| MD1224C2 (ro) | Utilizare a analogilor nucleozidici cu 1,3-oxatiolan în tratamentul hepatitei B | |
| CA2368615A1 (en) | Thiadiazolyl urea or thiourea derivatives for antiviral treatment | |
| CA2343204A1 (en) | Arylsulfonanilide ureas | |
| NL300344I1 (nl) | Nucleotide-analogen | |
| KR0141913B1 (en) | Anti-virus agents | |
| BR0011521A (pt) | Composto nucleósidos de purina de 4' -c-etinila | |
| BG104250A (en) | Levosimendan-containing composition for peroral administration | |
| MY123083A (en) | Acyclic nucleoside derivatives | |
| CA2365495A1 (en) | Viral treatment | |
| TW360652B (en) | Acryloyl substituted disstamycin derivatives, process for preparing them, and pharmaceutical composition comprising them | |
| DE69913499D1 (en) | Nucleoside | |
| CA2300289A1 (en) | A pharmaceutical composition active in reducing production of mcp-1 protein | |
| TR199902019T2 (xx) | �kame edilmi� tiazolidion' un haz�rlanmas� i�in proses. | |
| CA2204204A1 (en) | Carbohydrate derivatives | |
| AP9801235A0 (en) | Erythromycin derivatives. | |
| FI89594C (fi) | Foerfarande foer framstaellning av farmakologiskt vaerdefull pyrrolidinfoerening | |
| SE9902268D0 (sv) | Pharmaceutically active compounds | |
| DE60022047D1 (de) | Antivirale therapie | |
| AU1625795A (en) | Imidazopyridine derivatives and process for preparing the same | |
| AU4485101A (en) | Antiviral therapy | |
| CA2238516A1 (en) | Acyclic nucleoside derivatives |